One Stop Solution For In-Depth Market Research Reports

詳細な市場調査レポートのワンストップソリューション

Home    >    HEALTHCARE AND PHARMACEUTICALS   >   Embolic Protection Devices Market

[ 英語タイトル ] Embolic Protection Devices Market by Type (Distal Filter, Distal Occlusion, Proximal Occlusion), Material (Nitinol, Polyurethane), Application (Cardiovascular, Neurovascular, Peripheral), Indication (PCI, SVD, TAVR) - Global Forecast to 2023


Product Code : MNMHC00109399
Survey : MarketsandMarkets
Publish On : February, 2021
Category : Healthcare and Pharmaceuticals
Study Area : Global
Report format : PDF
Sales price option (consumption tax not included)
Single User USD5650 / Question Form
5 User USD6650 / Question Form
Enterprise User USD10000 / Question Form

[Report Description]

“Global embolic protection devices market projected to grow at a CAGR of 8.3%”
The global embolic protection devices market is projected to reach USD 604.9 million by 2023 from USD 405.5 million in 2018, at a CAGR of 8.3% during the forecast period. Factors such as the rising incidence of cardiovascular and neurovascular diseases, growing funding and investments, launch of technologically advanced embolic protection devices, and rising demand for minimally invasive procedures are expected to drive the growth of the market. However, product failure and recalls may restrain market growth to a certain extent.
“By type & material, the distal filters market & nitinol market held the largest market share in 2017”
By type, the global embolic protection devices market is segmented into distal filter devices, distal occlusion devices & proximal occlusion devices. By material, the global embolic protection devices market is segmented into plastic nitinol and polyurethane. In 2017, the distal filters segment dominated the embolic protection devices market by type and Nitinol dominated the embolic protection material market.
“By indication, the transcatheter aortic valve replacement segment is expected to grow at the highest CAGR during the forecast period”
On the basis of indication, the market is categorized into percutaneous coronary intervention, transcatheter aortic valve replacement (TAVR), carotid artery diseases, saphenous vein graft disease, and other indications. The transcatheter aortic valve replacement segment is expected to grow at the highest CAGR during the forecast period. The growth of this segment is driven by factors such as growing geriatric population, increasing obese population, increasing prevalence of aortic stenosis in heart patients, and rising demand for minimally invasive procedures.
“North America is expected to grow at the largest share during the forecast period (2018-2023)”
North America dominated the embolic protection devices market in 2017, followed by Europe. In North America, the US is expected to hold the largest share of the embolic protection devices market due to the rising prevalence of cardiovascular and neurovascular diseases, increasing adoption of minimally invasive techniques, increasing availability of funding to develop novel products, and the strong presence of device manufacturers in the country.
Break of primary participants was as mentioned below:
• By Company Type – Tier 1–45%, Tier 2–30% and Tier 3–25%
• By Designation – C-level–45%, Director Level–32%, Others–23%
• By Region – North America–46%, Europe–27%, Asia-Pacific–20%, Latin America–4%, Middle East & Africa- 3%

The major players in the embolic protection devices market are Boston Scientific (US), Medtronic (Ireland), Abbott (US), Cordis (A Cardinal Health Company) (US), Allium Medical (Israel), Contego Medical (US), W.L. Gore & Associates (US), Silk Road Medical (US), Claret Medical (US), and AngioSlide (Israel).
Research Coverage:
The embolic protection devices market in this report is segmented by type & material, application, indication, end user, and region. It provides detailed information regarding major factors influencing the market growth (drivers, restraints, opportunities, and industry-specific challenges). The study tracks and analyzes competitive developments (such as partnerships, agreements, collaborations, mergers, acquisitions, product development, geographical expansions, and R&D activities) and strategically profiles the key players and comprehensively analyzes their market shares and core competencies in the embolic protection devices market.
Reasons to buy this report:
From an insight perspective, this research report focuses on various levels of analysis—market share analysis of top players and company profiles which together comprise and discuss the basic views on the competitive landscape; emerging and high-growth segments of the embolic protection devices market; high-growth regions; and market drivers, restraints, and opportunities. The report provides the latest industry statistics and trends, allowing buyers to identify the high-growth product segments, potential customers, and suppliers hence driving revenue growth and profitability.

The report provides insights on the following pointers:
• Market Penetration: Comprehensive information on embolic devices offered by the top players in the global embolic protection devices market

• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and product launches in the embolic protection devices market

• Market Development: Comprehensive information about lucrative emerging markets – the report analyzes the markets for embolic protection devices market across regions

• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the global embolic protection devices market

• Competitive Assessment: In-depth assessment of market shares, strategies, products, and manufacturing capabilities of the leading players in the global embolic protection devices market

TABLE OF CONTENTS

1 INTRODUCTION 15
1.1 OBJECTIVES OF THE STUDY 15
1.2 DEFINITION 15
1.3 MARKET SCOPE 16
1.3.1 MARKETS COVERED 16
1.4 YEARS CONSIDERED FOR THE STUDY 16
1.5 CURRENCY 17
1.6 LIMITATIONS 17
1.7 STAKEHOLDERS 17
2 RESEARCH METHODOLOGY 18
2.1 RESEARCH DATA 18
2.1.1 SECONDARY SOURCES 19
2.1.1.1 Key data from secondary sources 19
2.1.2 PRIMARY SOURCES 20
2.1.2.1 Key data from primary sources 20
2.1.2.2 Key industry insights 21
2.1.2.3 Breakdown of primary interviews 21
2.2 MARKET SIZE ESTIMATION 22
2.2.1 BOTTOM-UP APPROACH 22
2.2.2 TOP-DOWN APPROACH 23
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 24
2.4 ASSUMPTIONS 25
3 EXECUTIVE SUMMARY 26
4 PREMIUM INSIGHTS 32
4.1 ATTRACTIVE OPPORTUNITIES IN THE EMBOLIC PROTECTION DEVICES MARKET 32
4.2 APAC: EMBOLIC PROTECTION DEVICES MARKET, BY INDICATION AND COUNTRY 33
4.3 GEOGRAPHIC SNAPSHOT OF THE EMBOLIC PROTECTION DEVICES MARKET 34
4.4 EMBOLIC PROTECTION DEVICES MARKET, BY TYPE, 35
4.5 EMBOLIC PROTECTION DEVICES MARKET: REGIONAL MIX 35

5 MARKET OVERVIEW 36
5.1 INTRODUCTION 37
5.2 MARKET DYNAMICS 37
5.2.1 DRIVERS 37
5.2.1.1 Rising incidence of cardiovascular & neurovascular diseases 37
5.2.1.2 Funding and investments for r&d on embolic protection devices 39
5.2.1.3 Technological advancements 39
5.2.1.4 Rising demand for minimally invasive procedures 40
5.2.2 RESTRAINT 40
5.2.2.1 Product failure and recalls 40
5.2.3 OPPORTUNITIE 41
5.2.3.1 Growth opportunities in emerging markets 41
5.2.4 CHALLENGES 42
5.2.4.1 Stringent regulatory scenario and unfavorable government policies 42
5.2.4.2 Dearth of skilled professionals 43
6 EMBOLIC PROTECTION DEVICES MARKET, BY TYPE & MATERIAL 44
6.1 EMBOLIC PROTECTION DEVICES MARKET, BY TYPE 45
6.1.1 DISTAL FILTER DEVICES 46
6.1.2 DISTAL OCCLUSION DEVICES 49
6.1.3 PROXIMAL OCCLUSION DEVICES 51
6.2 EMBOLIC PROTECTION DEVICES MARKET, BY MATERIAL 53
6.2.1 NITINOL 54
6.2.2 POLYURETHANE 55
7 EMBOLIC PROTECTION DEVICES MARKET, BY APPLICATION 56
7.1 INTRODUCTION 57
7.2 CARDIOVASCULAR DISEASES 58
7.3 NEUROVASCULAR DISEASES 60
7.4 PERIPHERAL VASCULAR DISEASES 61
8 EMBOLIC PROTECTION DEVICES MARKET, BY INDICATION 63
8.1 INTRODUCTION 64
8.2 PERCUTANEOUS CORONARY INTERVENTION 65
8.3 CAROTID ARTERY DISEASES 66
8.4 SAPHENOUS VEIN GRAFT DISEASE 67
8.5 TRANSCATHER AORTIC VALVE REPLACEMENT 68
8.6 OTHER INDICATIONS 69

9 EMBOLIC PROTECTION DEVICES MARKET, BY END USER 70
9.1 INTRODUCTION 71
9.2 HOSPITALS 72
9.3 AMBULATORY SURGICAL CENTERS 74
10 EMBOLIC PROTECTION DEVICES MARKET, BY REGION 76
10.1 INTRODUCTION 77
10.2 NORTH AMERICA 79
10.2.1 US 84
10.2.2 CANADA 87
10.3 EUROPE 90
10.3.1 GERMANY 95
10.3.2 FRANCE 98
10.3.3 UK 101
10.3.4 SPAIN 104
10.3.5 ITALY 107
10.3.6 REST OF EUROPE 110
10.4 ASIA PACIFIC 113
10.4.1 JAPAN 118
10.4.2 CHINA 121
10.4.3 INDIA 124
10.4.4 REST OF ASIA PACIFIC 127
10.5 LATIN AMERICA 130
10.6 MIDDLE EAST AND AFRICA 133
11 COMPETITIVE LANDSCAPE 137
11.1 OVERVIEW 137
11.2 RANKING FOR PLAYERS, 2017 138
11.3 COMPETITIVE SCENARIO 140
11.3.1 ACQUISITIONS 140
11.3.2 PRODUCT LAUNCHES 140
11.3.3 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS 141
11.3.4 EXPANSIONS 141

12 COMPANY PROFILES 142
(Overview, Strength of Product Portfolio, Business Strategy Excellence, Products Offering, and Recent Developments)*
12.1 MEDTRONIC 142
12.2 ABBOTT LABORATORIES 146
12.3 BOSTON SCIENTIFIC 149
12.4 CORDIS (A CARDINAL HEALTH COMPANY) 152
12.5 CONTEGO MEDICAL 155
12.6 W. L. GORE & ASSOCIATES 156
12.7 SILK ROAD MEDICAL 157
12.8 CLARET MEDICAL 158
12.9 ALLIUM MEDICAL SOLUTIONS 159
12.10 ANGIOSLIDE 160
*Details on Overview, Strength of Product Portfolio, Business Strategy Excellence, Products Offering, and Recent Developments might not be captured in case of unlisted companies.
13 APPENDIX 161
13.1 INSIGHTS OF INDUSTRY EXPERTS 161
13.2 DISCUSSION GUIDE 162
13.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 166
13.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 168
13.5 AVAILABLE CUSTOMIZATIONS 170
13.6 RELATED REPORTS 171
13.7 AUTHOR DETAILS 172

渋谷データカウント

渋谷データカウントは、最も信頼性が高く最新の調査分析レポートを確実に提供する経験豊富な調査専門家のグローバルチームが提供する、さまざまな業界のさまざまな市場調査レポートを提供する再販代理店です。

Recommended reports

+